VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Comment by snuff69on Feb 13, 2018 11:56pm

156 Views

Post# 27555339

RE:RE:RE:RE:RE:RE:FDA decision won't be long ...

I have a feeling we are going to hear something tommorow , three days finishing in the green , I can’t rember the last time that has happened and for some reason GA likes to have nrs on Wednesday’s ,two days prior to ce mark approval we had green days . We don’t get two many back to back green days and we now we have had three .
Good luck all

Bullboard Posts

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity